MedTrace Logo

Epidemiologic Register on Diabetes and COVID-19 in Tunisia

NCT05603130 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 811

Last updated 2022-11-02

No results posted yet for this study

Summary

CoviDTUN is a multicenter observatory set up by a steering committee to determine the presentation and evolution of diabetes in COVID-19 and study its pathogenesis.

The observatory comprises a dataset consisting of routinely collected clinical information anonymously to be entered by the investigator as a participating clinician/researcher.

The study will be an opportunity to understand the relationship between COVID-19 and diabetes, to enrich Tunisian data on diabetic and de novo diabetic patients who have contracted COVID-19 and to evaluate the prognostic severity factors for better management of these patients.

Conditions

  • COVID-19 Disease

Interventions

OTHER

routinely collected clinical information

medical history, epidemiological characteristics, clinical examination, biological assessment (blood glucose, NFS, CRP, D-dimer,etc...)

Sponsors & Collaborators

  • Les Laboratoires des Médicaments Stériles

    lead INDUSTRY

Principal Investigators

  • Faida AJILI, Pr. · Department of Internal Medicine at the Military Hospital of Tunis

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-23
Primary Completion
2022-06-30
Completion
2022-10-17

Countries

  • Tunisia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05603130 on ClinicalTrials.gov